Abstract
BackgroundBiologic agents are highly efficacious for treatment of rheumatoid arthritis (RA) (1). In 2010 recommendations from an international task force on treating RA to target (T2T) was published. (2) The...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have